Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=56560[graphic] This board acts as a portal for PVCT investors, and retains the right to refuse service to individuals not in compliance with reasonable, responsible, and intelligible posting practices. Please stay on topic. Provectus Pharmaceuticals is developing advanced therapies designed to target ...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=5656038013210pincusYeah, right. Still hard to fathom you posting on a board that isn't an "audience of interest."http://www.siliconinvestor.com/readmsg.aspx?msgid=289577346/18/2013 1:04:38 PMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289576396/18/2013 12:14:52 PMpincusOnce again, complaining about Connecting The Dots on a board that universally pans you. Oh, that's right. Yahoo isn't an "audience of interest." http://www.siliconinvestor.com/readmsg.aspx?msgid=289575886/18/2013 11:49:04 AMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289543566/16/2013 7:09:52 AMMimbariThank God they are. R&D companies never end up making money. And you have a problem with that? Tree hugging socialist.http://www.siliconinvestor.com/readmsg.aspx?msgid=289535776/15/2013 11:26:15 AMNTTGFunding the PIII will not be a problem for PVCT, the shelf is full of shares yet to be issued.....but that really isn't the point . They are set up as a licensing company, not an R&D company. If no license deal emerges I suspect they will take their patents and look for an alternate path to retirement....like they d...http://www.siliconinvestor.com/readmsg.aspx?msgid=289533586/15/2013 7:45:10 AMJack RussellI doubt that will happen... They will come up with the phase 3 finance if they have to...http://www.siliconinvestor.com/readmsg.aspx?msgid=289530976/14/2013 9:26:56 PMdirkdigglerAgreed. If the company is not listed, it will not go for much. That means getting some type of designation from the FDA what will spark interest in the company. If they have to go through a full blown PIII, they might go under due to funding and will force a fire sale. http://www.siliconinvestor.com/readmsg.aspx?msgid=289529996/14/2013 7:55:34 PMMimbariYes you are something out of a Mad Magazine. Lets wait to see what the dosing is when it comes out. http://www.siliconinvestor.com/readmsg.aspx?msgid=289525066/14/2013 2:35:46 PMNTTGNot at all, the company is on record stating they wanted more aggressive dosing....we know they will not get more aggressive disease state patients, so that is really the only out-standing issue to understanding how well the PIII trial design will play out....simple stuff My handlers? Like in the Cold War, spy vs sp...http://www.siliconinvestor.com/readmsg.aspx?msgid=289522606/14/2013 12:35:55 PMMimbarihttp://www.siliconinvestor.com/readmsg.aspx?msgid=289522216/14/2013 12:19:44 PMMimbariWhy is dosing so big to you right now? Did your handlers ask you to get that info?http://www.siliconinvestor.com/readmsg.aspx?msgid=289522196/14/2013 12:17:51 PMNTTGBased on the dosing information you recently 'discovered' I dont see much prospect for a valuable source on that point.http://www.siliconinvestor.com/readmsg.aspx?msgid=289521566/14/2013 11:48:58 AMMimbarihttp://www.siliconinvestor.com/readmsg.aspx?msgid=289520936/14/2013 11:19:09 AMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289520606/14/2013 11:05:49 AMMimbariThey were told by FDA to apply for BTD. Nttg, you need to quit stating things as facts when it is just your opinion. But I honestly think you believe in the drug or you would not be here at all. You just enjoy bashing the company out of some personal vendetta.http://www.siliconinvestor.com/readmsg.aspx?msgid=289520136/14/2013 10:38:56 AMMimbariDisagree. Most large investment firms are not allowed to buy the stock until it gets listed.http://www.siliconinvestor.com/readmsg.aspx?msgid=289520006/14/2013 10:33:18 AMNTTGNeither option is a likely outcome here. Look at the molecules that have gotten BTD, then look at what is known about RB. The 'currency' for acceptable outcomes here is the demonstration of MOA knowledge and principles that the scientific and clinical community (not a small group of vested owners) both accept and ar...http://www.siliconinvestor.com/readmsg.aspx?msgid=289517596/14/2013 7:20:14 AMJack RussellThe listing on Nasdaq makes a ton of difference... People in general will not invest a "Boatload of Money" as I heard someone else say in an OTC stock.http://www.siliconinvestor.com/readmsg.aspx?msgid=289514666/13/2013 10:35:10 PMdirkdigglerIf in fact they do some type of designation from the FDA, the listing of the on Nasq probably won't matter except internal company politics of the acquiring company ie. Easier for the board the give approval for purchase. http://www.siliconinvestor.com/readmsg.aspx?msgid=289514396/13/2013 10:17:51 PMNTTGMost of the delays are the result of poor planning at PVCT and over interpretation of their data. Everyone knew in 2010 that PVCT would have to do work on MOA, most companies are well into these studies by the end of PII clinical trials, not PVCT. Lots of drugs moved forward during the 'FDA change" of 2011, PVCT is st...http://www.siliconinvestor.com/readmsg.aspx?msgid=289507136/13/2013 4:10:06 PMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289506816/13/2013 3:55:43 PMMimbariWell I asked those that know something in the industry about regional deals. Here is impression I got. Big pharmas do want bolt-on's because they are poor at picking a good drug. They have been getting burned. Counter intuitively they are all saying they would rather make less and allow regional deals done than take t...http://www.siliconinvestor.com/readmsg.aspx?msgid=289506416/13/2013 3:43:00 PMpincushttp://www.siliconinvestor.com/readmsg.aspx?msgid=289506176/13/2013 3:36:29 PMdirkdigglerHere's the problem. 1. I wouldn't have any problem with the stock going down if Mgt came through on just one of their assertions. 2. All I heard after PII was AA. Then it switched to SPA. Which we were supposed to get according to Mgt End Q2 2012. Now there going for BTD. They could have an SPA start the trial an...http://www.siliconinvestor.com/readmsg.aspx?msgid=289504266/13/2013 2:34:12 PMMimbariNow that PVCT has locked up the patent for RB for 17 years lets look at what that means to future income. Consider that eventually they get five regional deals worth about one billion in sales each per year. This is just hypothetical speak. Now if they get 25% royalty payments then they would receive 1.25 billion per y...http://www.siliconinvestor.com/readmsg.aspx?msgid=289504236/13/2013 2:33:24 PMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289502076/13/2013 1:20:08 PMpincushttp://www.siliconinvestor.com/readmsg.aspx?msgid=289499846/13/2013 11:55:49 AMMimbariSelling licenses to different regions is a way to give value to the companies share price. Selling the global license gives the buyer the rights to the income from the regional licenses. In my opinion that amounts to 25%-30% royalty payments from the drug sales. http://www.siliconinvestor.com/readmsg.aspx?msgid=289499056/13/2013 11:31:03 AMMimbarihttp://www.siliconinvestor.com/readmsg.aspx?msgid=289498826/13/2013 11:24:38 AMjm2i1231.you clearly have no knowledge or experience of how things work between phase2 and phase3. Yes things take forever. and that's the nature of the beast. Find me one investor, ONE, who says his/her biotech FDA-passed trials super fast, data released fast etc..etc..especially between phase2 and phase3 (and furthermore wh...http://www.siliconinvestor.com/readmsg.aspx?msgid=289498176/13/2013 11:05:03 AMNTTGThe company was slow to 'lock data' after completion of the PII trial; then they had to confront the poor clinical response in stage IV and nodal stage III patients (now to be excluded from phase III trial design). It is likely that they tried several times to convince FDA that increased cumulative dosing should be al...http://www.siliconinvestor.com/readmsg.aspx?msgid=289491016/12/2013 11:37:18 PMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289490546/12/2013 10:55:47 PMNTTGBecause of the imaging needed to document a secondary 'bystander' end-point, the per-patient cost of this trial will be higher than most PIII trials....http://www.siliconinvestor.com/readmsg.aspx?msgid=289490496/12/2013 10:53:51 PMNTTGcost of the drug is budget dust for PIII trials, and approval has nothing to do with fundinghttp://www.siliconinvestor.com/readmsg.aspx?msgid=289490446/12/2013 10:49:50 PMdirkdigglerHere's my problem with your thought process. Then why is it taking 3 years to start PIII. I lost a boat load of money in this and I'm tired of the hype. Sell the company now. I have experience in buy outs and no one wants regional deals. It's all or non when it comes to acquisitions. http://www.siliconinvestor.com/readmsg.aspx?msgid=289487986/12/2013 8:24:53 PMdirkdigglerUnfortunately, this is what I have read. So, let's just say I'm a big Pharma Co. and I want to buy PVCT. I can just wait them out and get a sweet heart deal. Three year since PII ended and no PIII start isn't helping their position. Thay only ones making out in this stock is management. http://www.siliconinvestor.com/readmsg.aspx?msgid=289487926/12/2013 8:20:28 PMjm2i123Don't you understand that a phase 3 trial approval most always means signing a licensing deal in this market?...also because the drug is cheap to produce and if it's SPA, a few millions will do (btw check the top biotech ceo's out there...it still is below..). Game changer.http://www.siliconinvestor.com/readmsg.aspx?msgid=289485856/12/2013 6:08:18 PMboomertree2Phase III drug trials can easily cost in the 100's of millions of dollars. I have seen estimates given for the modest 180 patient PV-10 phase III trial at $9 to $15 million. The Company presently only has $5 million. If you look at the Company historical annual cash burn rate, more money has been spent on executive off...http://www.siliconinvestor.com/readmsg.aspx?msgid=289485656/12/2013 5:54:39 PMpincusGiven the universal negative reactions to your posts on Yahoo, that must be a small group.http://www.siliconinvestor.com/readmsg.aspx?msgid=289482646/12/2013 3:19:33 PMdirkdigglerhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289481866/12/2013 2:46:44 PMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289480466/12/2013 2:07:14 PMpincusPumpers? That is a laugh. You seem obsessed by Connecting the Dots and use these boards to respond. Why not start your own blog? Then people could come to you for your advice.http://www.siliconinvestor.com/readmsg.aspx?msgid=289478536/12/2013 1:04:20 PMJack Russellhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289476586/12/2013 11:57:04 AMNTTGhttp://www.siliconinvestor.com/readmsg.aspx?msgid=289474876/12/2013 11:02:42 AMJack RussellWho here is pumping? If you think someone here is you also don't understand what pumping is. And no you will not be "Voted Off". I think most reasonable people see you for what you are...http://www.siliconinvestor.com/readmsg.aspx?msgid=289474576/12/2013 10:50:24 AMJack RussellEither that or what others say is true He was outed for less than Ethical behavior by one of the principals of PVCT...http://www.siliconinvestor.com/readmsg.aspx?msgid=289474446/12/2013 10:46:37 AMMimbarihttp://www.siliconinvestor.com/readmsg.aspx?msgid=289458126/11/2013 1:46:36 PMMimbarihttp://www.siliconinvestor.com/readmsg.aspx?msgid=289458096/11/2013 1:45:41 PMNTTGThat has been tried before. Turns out there are readers who appreciate the alternate points of view from the pumpershttp://www.siliconinvestor.com/readmsg.aspx?msgid=289455086/11/2013 11:57:46 AM